Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
KROS
NAUT
Add up to 3 more stocks
KROS
Keros Therapeutics, Inc.
-2.26%
$11.26-0.26Delayed quote: Oct 6, 2026, 2:10 PM EDT
Market Cap
$223.25M
52W Range
$9.69 - $22.55
NAUT
Nautilus Biotechnolgy, Inc.
-1.64%
$1.84-0.03Delayed quote: Oct 6, 2026, 2:10 PM EDT
Market Cap
$234.06M
52W Range
$0.82 - $4.31
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.85 | 1.79 |
| P/S Ratio | 14.87 | 1231.90 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 94.7% | 0.0% |
| Operating Margin | 28.9% | 0.0% |
| Net Margin | -553.9% | -29747.9% |
| ROE | -31.7% | -43.1% |
| ROA | -28.9% | -34.5% |
| ROIC | -36.5% | -40.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 21.96 | 10.14 |
| Quick Ratio | 21.96 | 10.14 |
| Debt/Equity | 0.06 | 0.21 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.